ICD-10-CM Billable Code

H16.409

Unspecified corneal neovascularization, unspecified eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Corneal neovascularization refers to the abnormal growth of blood vessels into the cornea, the transparent front part of the eye. When this condition occurs, it can impair vision and cause discomfort. The ICD-10 code H16.409 describes an unspecified form of corneal neovascularization in an unspecified eye, highlighting that the specific details about the eye or the extent of the condition are not specified. Understanding this condition is essential for patients and caregivers to recognize symptoms and seek appropriate care.

Causes & Symptoms

Clinical Causes: Chronic ocular surface inflammation such as conjunctivitis or keratitis Contact lens overuse or improper hygiene Ocular trauma or injury Corneal hypoxia due to prolonged contact lens wear Previous eye surgeries or procedures Infections affecting the cornea Degenerative corneal diseases Exposure to environmental irritants or chemicals

Key Symptoms: Redness of the eye Blurred or decreased vision Sensitivity to light (photophobia) Discomfort, burning, or foreign body sensation Appearance of blood vessels growing into the cornea Possible tearing or excessive watering of the eye Reduced visual clarity due to corneal opacity

Diagnostic & Treatment

Diagnosis Path: Diagnosing corneal neovascularization involves a thorough eye examination by an eye care professional. They typically use slit-lamp biomicroscopy to observe the corneal surface closely. Additional tests might include fluorescein staining to assess corneal integrity or imaging techniques to evaluate the extent of blood vessel growth. A comprehensive history helps identify possible causes, such as contact lens use or previous trauma. Proper diagnosis is vital in determining the appropriate management plan.

Treatment Protocols: Treatment options aim to reduce abnormal blood vessel growth, address underlying causes, and preserve vision. These may include: - Managing underlying inflammation with medications such as corticosteroids or immunosuppressive drugs. - Discontinuing or adjusting contact lens use if related to hypoxia. - Surgical interventions like laser therapy or vessel cauterization in severe cases. - Use of anti-angiogenic medications that inhibit blood vessel growth. - Regular monitoring to prevent progression and assess response to therapy. It is essential for patients to follow their eye care provider's recommendations closely to prevent further complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H16.409 a billable ICD-10 code?
Yes, H16.409 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H16.409?
Clinical documentation must specify the nature of Unspecified corneal neovascularization, unspecified eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference